Therapeutic method for treatment of carcinoma or autoimmune dise

Details Therapeutic method for treatment of carcinoma or autoimmune dise Therapeutic method for treatment of carcinoma or autoimmune dise

1996-11-22

1998-07-14

Davenport, Avis M.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514 2, 530324, A61K 3800, A61K 3802, C07K 500, C07K 700

Patent

active

057804320

ABSTRACT:
A therapeutic method for treatment of carcinoma or autoimmune diseases of a patient, which includes administering to said patient a biologically active composition which comprises a therapeutically acceptable carrier and, in a quantity having a therapeutic effect, two active substances comprising a pure cytostatic drug as the first active substance and a biologically active pure histone selected from the group consisting of H1, H2A, H2B, H2A:H2B, and H3 as the second active substance, providing a synergistic action of both of said active substances at a site of pathogenic process of said patient.

REFERENCES:
patent: 4818763 (1989-04-01), Rusch et al.
patent: 4902505 (1990-02-01), Pardridge et al.
patent: 5578571 (1996-11-01), Zeppezauer et al.

Affiliated with

Also associated with

Rating

Therapeutic method for treatment of carcinoma or autoimmune dise does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Therapeutic method for treatment of carcinoma or autoimmune dise, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic method for treatment of carcinoma or autoimmune dise will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1881748